News Releases

Mayo Clinic has launched a new SARS-CoV-2 neutralizing antibody test in support of the national Expanded Access Program for Convalescent Plasma and other critical research efforts to establish effective therapies and vaccines for COVID-19.

By Andy Tofilon • June 12, 2020

Thermo Fisher Scientific Inc. announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.

By Andy Tofilon • May 13, 2020

Mayo Clinic joined Minnesota Gov. Tim Walz, Minnesota Department of Health Commissioner Jan Malcom, the University of Minnesota, and other health system leaders to announce a breakthrough initiative to provide rapid, widespread testing for COVID-19 in Minnesota.

By Andy Tofilon • April 23, 2020

A new serology test from Mayo Clinic Laboratories that is used to identify the presence of immune response to SARS-CoV-2, the virus that causes COVID-19, is now available to more health care organizations.

By Andy Tofilon • April 13, 2020

Mayo Clinic will be the lead institution providing coordinated access to investigational convalescent plasma for hospitalized patients with severe or life-threatening COVID-19, or those at high risk of progression to severe or life-threatening disease. The Food and Drug Administration (FDA) announced the designation on Friday, April 3.

By Andy Tofilon • April 3, 2020

Mayo Clinic has significantly expanded its capacity to test clinical samples for SARS-CoV-2, the virus that causes COVID-19. With new equipment that went online Tuesday, Mayo Clinic Laboratories now has the capacity to process COVID-19 test samples from all Mayo Clinic sites. In addition, it has begun processing test samples from its clients across Minnesota, including eight major health systems.

By Andy Tofilon • March 19, 2020

Mayo Clinic has developed a test that can detect the SARS-CoV-2 virus in clinical samples. The SARS-CoV-2 virus causes COVID-19. The test, “Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2), Molecular Detection” has been fully validated.

By Andy Tofilon • March 12, 2020